nodes	percent_of_prediction	percent_of_DWPC	metapath
Idarubicin—TOP2A—polycystic ovary syndrome	0.902	1	CbGaD
Idarubicin—CYP2C9—urine—polycystic ovary syndrome	0.00388	0.141	CbGeAlD
Idarubicin—Valrubicin—TOP2A—polycystic ovary syndrome	0.00369	0.379	CrCbGaD
Idarubicin—CYP2D6—urine—polycystic ovary syndrome	0.00292	0.106	CbGeAlD
Idarubicin—TOP2A—endometrium—polycystic ovary syndrome	0.00202	0.0734	CbGeAlD
Idarubicin—TOP2A—uterus—polycystic ovary syndrome	0.00186	0.0676	CbGeAlD
Idarubicin—TOP2A—adipose tissue—polycystic ovary syndrome	0.00182	0.0661	CbGeAlD
Idarubicin—Doxorubicin—AKR1C3—polycystic ovary syndrome	0.00176	0.181	CrCbGaD
Idarubicin—TOP2A—adrenal gland—polycystic ovary syndrome	0.00163	0.0593	CbGeAlD
Idarubicin—Epirubicin—TOP2A—polycystic ovary syndrome	0.00161	0.165	CrCbGaD
Idarubicin—TOP2A—female gonad—polycystic ovary syndrome	0.00152	0.0553	CbGeAlD
Idarubicin—TOP2A—vagina—polycystic ovary syndrome	0.00151	0.055	CbGeAlD
Idarubicin—ABCC1—adrenal cortex—polycystic ovary syndrome	0.00136	0.0495	CbGeAlD
Idarubicin—ABCC1—endometrium—polycystic ovary syndrome	0.00122	0.0442	CbGeAlD
Idarubicin—Daunorubicin—TOP2A—polycystic ovary syndrome	0.00114	0.117	CrCbGaD
Idarubicin—ABCC1—uterus—polycystic ovary syndrome	0.00112	0.0407	CbGeAlD
Idarubicin—ABCC1—pituitary gland—polycystic ovary syndrome	0.0011	0.04	CbGeAlD
Idarubicin—ABCC1—adipose tissue—polycystic ovary syndrome	0.0011	0.0398	CbGeAlD
Idarubicin—ABCC1—adrenal gland—polycystic ovary syndrome	0.000982	0.0357	CbGeAlD
Idarubicin—Doxorubicin—TOP2A—polycystic ovary syndrome	0.000923	0.0949	CrCbGaD
Idarubicin—ABCC1—female gonad—polycystic ovary syndrome	0.000916	0.0333	CbGeAlD
Idarubicin—ABCC1—vagina—polycystic ovary syndrome	0.00091	0.0331	CbGeAlD
Idarubicin—CYP2C9—endocrine gland—polycystic ovary syndrome	0.000644	0.0234	CbGeAlD
Idarubicin—Daunorubicin—CYP1A1—polycystic ovary syndrome	0.000608	0.0625	CrCbGaD
Idarubicin—CYP2D6—female gonad—polycystic ovary syndrome	0.00052	0.0189	CbGeAlD
Idarubicin—CYP2D6—endocrine gland—polycystic ovary syndrome	0.000483	0.0176	CbGeAlD
Idarubicin—TOP2A—Circadian rythm related genes—NAMPT—polycystic ovary syndrome	0.000295	0.00484	CbGpPWpGaD
Idarubicin—ABCC1—Transmembrane transport of small molecules—ABCB6—polycystic ovary syndrome	0.000285	0.00468	CbGpPWpGaD
Idarubicin—CYP2C9—Arachidonic acid metabolism—AKR1C3—polycystic ovary syndrome	0.000257	0.00423	CbGpPWpGaD
Idarubicin—CYP2D6—Melatonin metabolism and effects—CYP1A1—polycystic ovary syndrome	0.000252	0.00414	CbGpPWpGaD
Idarubicin—TOP2A—Circadian rythm related genes—GHRL—polycystic ovary syndrome	0.000249	0.00409	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism of lipids and lipoproteins—LPCAT2—polycystic ovary syndrome	0.000245	0.00402	CbGpPWpGaD
Idarubicin—TOP2A—Circadian rythm related genes—ADIPOQ—polycystic ovary syndrome	0.000241	0.00396	CbGpPWpGaD
Idarubicin—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP11A1—polycystic ovary syndrome	0.000238	0.0039	CbGpPWpGaD
Idarubicin—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP11A1—polycystic ovary syndrome	0.000236	0.00387	CbGpPWpGaD
Idarubicin—CYP2D6—Oxidation by Cytochrome P450—CYP11A1—polycystic ovary syndrome	0.000235	0.00385	CbGpPWpGaD
Idarubicin—TOP2A—Circadian rythm related genes—TH—polycystic ovary syndrome	0.000234	0.00385	CbGpPWpGaD
Idarubicin—CYP2C9—Oxidation by Cytochrome P450—CYP11A1—polycystic ovary syndrome	0.000233	0.00382	CbGpPWpGaD
Idarubicin—CYP2D6—Metapathway biotransformation—AKR1C2—polycystic ovary syndrome	0.000223	0.00365	CbGpPWpGaD
Idarubicin—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP17A1—polycystic ovary syndrome	0.000221	0.00363	CbGpPWpGaD
Idarubicin—CYP2C9—Metapathway biotransformation—AKR1C2—polycystic ovary syndrome	0.000221	0.00362	CbGpPWpGaD
Idarubicin—TOP2A—Circadian rythm related genes—NGFR—polycystic ovary syndrome	0.000219	0.0036	CbGpPWpGaD
Idarubicin—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP17A1—polycystic ovary syndrome	0.000219	0.0036	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle, Mitotic—CCNE2—polycystic ovary syndrome	0.000219	0.00359	CbGpPWpGaD
Idarubicin—CYP2D6—Oxidation by Cytochrome P450—CYP17A1—polycystic ovary syndrome	0.000218	0.00358	CbGpPWpGaD
Idarubicin—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—polycystic ovary syndrome	0.000218	0.00357	CbGpPWpGaD
Idarubicin—TOP2A—Integrated Pancreatic Cancer Pathway—AR—polycystic ovary syndrome	0.000217	0.00356	CbGpPWpGaD
Idarubicin—CYP2C9—Oxidation by Cytochrome P450—CYP17A1—polycystic ovary syndrome	0.000216	0.00355	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle, Mitotic—CDC6—polycystic ovary syndrome	0.000206	0.00338	CbGpPWpGaD
Idarubicin—ABCC1—Transmembrane transport of small molecules—TRPV6—polycystic ovary syndrome	0.000203	0.00334	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle—CCNE2—polycystic ovary syndrome	0.000196	0.00321	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism of lipids and lipoproteins—TEAD2—polycystic ovary syndrome	0.000193	0.00317	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism of lipids and lipoproteins—AKR1C2—polycystic ovary syndrome	0.000193	0.00317	CbGpPWpGaD
Idarubicin—CYP2D6—Phase 1 - Functionalization of compounds—CYP11A1—polycystic ovary syndrome	0.000193	0.00316	CbGpPWpGaD
Idarubicin—CYP2C9—Phase 1 - Functionalization of compounds—CYP11A1—polycystic ovary syndrome	0.000191	0.00314	CbGpPWpGaD
Idarubicin—TOP2A—Integrated Pancreatic Cancer Pathway—BAX—polycystic ovary syndrome	0.000185	0.00304	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle—CDC6—polycystic ovary syndrome	0.000184	0.00302	CbGpPWpGaD
Idarubicin—ABCC1—Transmembrane transport of small molecules—SCNN1A—polycystic ovary syndrome	0.000184	0.00302	CbGpPWpGaD
Idarubicin—TOP2A—Circadian rythm related genes—NCOR1—polycystic ovary syndrome	0.000182	0.00299	CbGpPWpGaD
Idarubicin—CYP2D6—Phase 1 - Functionalization of compounds—CYP17A1—polycystic ovary syndrome	0.000179	0.00294	CbGpPWpGaD
Idarubicin—CYP2C9—Phase 1 - Functionalization of compounds—CYP17A1—polycystic ovary syndrome	0.000178	0.00292	CbGpPWpGaD
Idarubicin—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP19A1—polycystic ovary syndrome	0.000175	0.00287	CbGpPWpGaD
Idarubicin—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP19A1—polycystic ovary syndrome	0.000173	0.00285	CbGpPWpGaD
Idarubicin—CYP2D6—Oxidation by Cytochrome P450—CYP19A1—polycystic ovary syndrome	0.000173	0.00283	CbGpPWpGaD
Idarubicin—CYP2C9—Oxidation by Cytochrome P450—CYP19A1—polycystic ovary syndrome	0.000171	0.00281	CbGpPWpGaD
Idarubicin—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—polycystic ovary syndrome	0.000166	0.00273	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	0.000162	0.00266	CbGpPWpGaD
Idarubicin—CYP2C9—Arachidonic acid metabolism—CYP1A1—polycystic ovary syndrome	0.000162	0.00265	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle, Mitotic—RRM2—polycystic ovary syndrome	0.000161	0.00264	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	0.000154	0.00252	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle, Mitotic—MAD2L1—polycystic ovary syndrome	0.000152	0.00249	CbGpPWpGaD
Idarubicin—TOP2A—Circadian rythm related genes—LEP—polycystic ovary syndrome	0.00015	0.00246	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	0.000147	0.00241	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle—RRM2—polycystic ovary syndrome	0.000144	0.00236	CbGpPWpGaD
Idarubicin—ABCC1—Disease—NMNAT3—polycystic ovary syndrome	0.000142	0.00233	CbGpPWpGaD
Idarubicin—CYP2D6—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	0.000142	0.00233	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle, Mitotic—LMNA—polycystic ovary syndrome	0.000141	0.00231	CbGpPWpGaD
Idarubicin—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	0.000141	0.00231	CbGpPWpGaD
Idarubicin—CYP2C9—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	0.000141	0.00231	CbGpPWpGaD
Idarubicin—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	0.00014	0.00229	CbGpPWpGaD
Idarubicin—CYP2D6—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	0.000139	0.00228	CbGpPWpGaD
Idarubicin—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	0.000138	0.00226	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle—MAD2L1—polycystic ovary syndrome	0.000136	0.00223	CbGpPWpGaD
Idarubicin—TOP2A—Circadian rythm related genes—PPARG—polycystic ovary syndrome	0.000131	0.00214	CbGpPWpGaD
Idarubicin—TOP2A—Integrated Pancreatic Cancer Pathway—IGF1—polycystic ovary syndrome	0.000129	0.00212	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle—LMNA—polycystic ovary syndrome	0.000126	0.00207	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	0.000125	0.00205	CbGpPWpGaD
Idarubicin—CYP2D6—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	0.000124	0.00203	CbGpPWpGaD
Idarubicin—CYP2C9—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	0.000123	0.00202	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle, Mitotic—CCNB1—polycystic ovary syndrome	0.000122	0.002	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—NMNAT3—polycystic ovary syndrome	0.000119	0.00196	CbGpPWpGaD
Idarubicin—TOP2A—Circadian rythm related genes—SERPINE1—polycystic ovary syndrome	0.000118	0.00193	CbGpPWpGaD
Idarubicin—CYP2D6—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.000116	0.0019	CbGpPWpGaD
Idarubicin—CYP2C9—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.000115	0.00188	CbGpPWpGaD
Idarubicin—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	0.000114	0.00188	CbGpPWpGaD
Idarubicin—CYP2D6—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	0.000114	0.00187	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	0.000114	0.00187	CbGpPWpGaD
Idarubicin—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	0.000113	0.00186	CbGpPWpGaD
Idarubicin—CYP2C9—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	0.000113	0.00185	CbGpPWpGaD
Idarubicin—TOP2A—Integrated Pancreatic Cancer Pathway—BCL2—polycystic ovary syndrome	0.000113	0.00185	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	0.000111	0.00182	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—LPCAT2—polycystic ovary syndrome	0.000109	0.00179	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—SUOX—polycystic ovary syndrome	0.000109	0.00179	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle—CCNB1—polycystic ovary syndrome	0.000109	0.00179	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism of lipids and lipoproteins—LPCAT2—polycystic ovary syndrome	0.000109	0.00178	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	0.000108	0.00177	CbGpPWpGaD
Idarubicin—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	0.000105	0.00173	CbGpPWpGaD
Idarubicin—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	0.000104	0.00171	CbGpPWpGaD
Idarubicin—CYP2D6—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.000102	0.00168	CbGpPWpGaD
Idarubicin—CYP2C9—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.000101	0.00167	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—ISYNA1—polycystic ovary syndrome	0.000101	0.00166	CbGpPWpGaD
Idarubicin—CYP2D6—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.000101	0.00166	CbGpPWpGaD
Idarubicin—CYP2C9—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.0001	0.00164	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	9.9e-05	0.00162	CbGpPWpGaD
Idarubicin—CYP2D6—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	9.53e-05	0.00157	CbGpPWpGaD
Idarubicin—CYP2D6—Biological oxidations—CYP17A1—polycystic ovary syndrome	9.52e-05	0.00156	CbGpPWpGaD
Idarubicin—CYP2C9—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	9.45e-05	0.00155	CbGpPWpGaD
Idarubicin—CYP2C9—Biological oxidations—CYP17A1—polycystic ovary syndrome	9.43e-05	0.00155	CbGpPWpGaD
Idarubicin—CYP2D6—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	9.39e-05	0.00154	CbGpPWpGaD
Idarubicin—CYP2C9—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	9.3e-05	0.00153	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	9.24e-05	0.00152	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	8.77e-05	0.00144	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—AKR1C2—polycystic ovary syndrome	8.61e-05	0.00141	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—TEAD2—polycystic ovary syndrome	8.61e-05	0.00141	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C2—polycystic ovary syndrome	8.59e-05	0.00141	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism of lipids and lipoproteins—TEAD2—polycystic ovary syndrome	8.59e-05	0.00141	CbGpPWpGaD
Idarubicin—CYP2D6—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	8.52e-05	0.0014	CbGpPWpGaD
Idarubicin—CYP2C9—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	8.45e-05	0.00139	CbGpPWpGaD
Idarubicin—TOP2A—Integrated Pancreatic Cancer Pathway—VEGFA—polycystic ovary syndrome	8.43e-05	0.00138	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	8.28e-05	0.00136	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	8.15e-05	0.00134	CbGpPWpGaD
Idarubicin—ABCC1—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	7.67e-05	0.00126	CbGpPWpGaD
Idarubicin—CYP2D6—Biological oxidations—CYP19A1—polycystic ovary syndrome	7.53e-05	0.00124	CbGpPWpGaD
Idarubicin—CYP2C9—Biological oxidations—CYP19A1—polycystic ovary syndrome	7.47e-05	0.00123	CbGpPWpGaD
Idarubicin—CYP2D6—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	7.43e-05	0.00122	CbGpPWpGaD
Idarubicin—CYP2C9—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	7.36e-05	0.00121	CbGpPWpGaD
Idarubicin—ABCC1—Disease—RPL37A—polycystic ovary syndrome	7.33e-05	0.0012	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—PNPLA2—polycystic ovary syndrome	7.22e-05	0.00118	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	7.2e-05	0.00118	CbGpPWpGaD
Idarubicin—ABCC1—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	7.13e-05	0.00117	CbGpPWpGaD
Idarubicin—ABCC1—Disease—HMMR—polycystic ovary syndrome	6.95e-05	0.00114	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—SRD5A1—polycystic ovary syndrome	6.84e-05	0.00112	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	6.83e-05	0.00112	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—STAR—polycystic ovary syndrome	6.53e-05	0.00107	CbGpPWpGaD
Idarubicin—ABCC1—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	6.52e-05	0.00107	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	6.51e-05	0.00107	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	6.45e-05	0.00106	CbGpPWpGaD
Idarubicin—CYP2D6—Biological oxidations—CYP1A1—polycystic ovary syndrome	6.07e-05	0.000997	CbGpPWpGaD
Idarubicin—CYP2C9—Biological oxidations—CYP1A1—polycystic ovary syndrome	6.02e-05	0.000988	CbGpPWpGaD
Idarubicin—CYP2D6—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	5.99e-05	0.000983	CbGpPWpGaD
Idarubicin—CYP2C9—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	5.94e-05	0.000974	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—HMMR—polycystic ovary syndrome	5.82e-05	0.000955	CbGpPWpGaD
Idarubicin—ABCC1—Disease—AKR1C1—polycystic ovary syndrome	5.72e-05	0.000939	CbGpPWpGaD
Idarubicin—TOP2A—Circadian rythm related genes—IL6—polycystic ovary syndrome	5.6e-05	0.000919	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—HSD3B1—polycystic ovary syndrome	5.55e-05	0.000911	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	5.54e-05	0.000909	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	5.49e-05	0.0009	CbGpPWpGaD
Idarubicin—ABCC1—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	5.47e-05	0.000899	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—NMNAT3—polycystic ovary syndrome	5.34e-05	0.000877	CbGpPWpGaD
Idarubicin—ABCC1—Disease—FGF18—polycystic ovary syndrome	5.31e-05	0.000871	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—NMNAT3—polycystic ovary syndrome	5.29e-05	0.000869	CbGpPWpGaD
Idarubicin—ABCC1—Disease—RBP4—polycystic ovary syndrome	5.26e-05	0.000864	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	5.2e-05	0.000854	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—LHB—polycystic ovary syndrome	5.06e-05	0.000831	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	5.05e-05	0.000829	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—HSD3B2—polycystic ovary syndrome	4.95e-05	0.000812	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	4.94e-05	0.00081	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—LPCAT2—polycystic ovary syndrome	4.88e-05	0.000802	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—SUOX—polycystic ovary syndrome	4.88e-05	0.000802	CbGpPWpGaD
Idarubicin—ABCC1—Disease—GAB1—polycystic ovary syndrome	4.85e-05	0.000796	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—LPCAT2—polycystic ovary syndrome	4.84e-05	0.000795	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—SUOX—polycystic ovary syndrome	4.84e-05	0.000795	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—AKR1C1—polycystic ovary syndrome	4.79e-05	0.000786	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	4.78e-05	0.000785	CbGpPWpGaD
Idarubicin—ABCC1—Disease—NAMPT—polycystic ovary syndrome	4.72e-05	0.000775	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—ISYNA1—polycystic ovary syndrome	4.54e-05	0.000745	CbGpPWpGaD
Idarubicin—CYP2D6—Biological oxidations—POMC—polycystic ovary syndrome	4.53e-05	0.000743	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—ISYNA1—polycystic ovary syndrome	4.5e-05	0.000739	CbGpPWpGaD
Idarubicin—CYP2C9—Biological oxidations—POMC—polycystic ovary syndrome	4.49e-05	0.000737	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—SULT2A1—polycystic ovary syndrome	4.41e-05	0.000724	CbGpPWpGaD
Idarubicin—ABCC1—Disease—AKR1C3—polycystic ovary syndrome	4.4e-05	0.000723	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	4.4e-05	0.000722	CbGpPWpGaD
Idarubicin—ABCC1—Disease—TNRC6B—polycystic ovary syndrome	4.33e-05	0.000712	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—RRM2—polycystic ovary syndrome	4.27e-05	0.000701	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—YAP1—polycystic ovary syndrome	4.12e-05	0.000676	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	4.11e-05	0.000674	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—NAMPT—polycystic ovary syndrome	3.95e-05	0.000649	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	3.93e-05	0.000645	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—CYP11A1—polycystic ovary syndrome	3.9e-05	0.000641	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	3.9e-05	0.00064	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	3.88e-05	0.000636	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—AKR1C2—polycystic ovary syndrome	3.86e-05	0.000634	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—TEAD2—polycystic ovary syndrome	3.86e-05	0.000634	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—TEAD2—polycystic ovary syndrome	3.83e-05	0.000628	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—AKR1C2—polycystic ovary syndrome	3.83e-05	0.000628	CbGpPWpGaD
Idarubicin—ABCC1—Disease—TCF7L2—polycystic ovary syndrome	3.71e-05	0.000609	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—AKR1C3—polycystic ovary syndrome	3.69e-05	0.000605	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	3.68e-05	0.000604	CbGpPWpGaD
Idarubicin—ABCC1—Disease—SLC2A4—polycystic ovary syndrome	3.65e-05	0.000599	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—CYP17A1—polycystic ovary syndrome	3.63e-05	0.000596	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	3.62e-05	0.000595	CbGpPWpGaD
Idarubicin—ABCC1—Disease—PRL—polycystic ovary syndrome	3.48e-05	0.000571	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—PNPLA2—polycystic ovary syndrome	3.24e-05	0.000531	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—PNPLA2—polycystic ovary syndrome	3.21e-05	0.000526	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—TH—polycystic ovary syndrome	3.14e-05	0.000516	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—SRD5A1—polycystic ovary syndrome	3.07e-05	0.000503	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—SLC2A4—polycystic ovary syndrome	3.06e-05	0.000502	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—SRD5A1—polycystic ovary syndrome	3.04e-05	0.000499	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—STAR—polycystic ovary syndrome	2.93e-05	0.00048	CbGpPWpGaD
Idarubicin—ABCC1—Disease—NCOR1—polycystic ovary syndrome	2.92e-05	0.000479	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—STAR—polycystic ovary syndrome	2.9e-05	0.000476	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—CYP19A1—polycystic ovary syndrome	2.87e-05	0.000472	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	2.87e-05	0.000471	CbGpPWpGaD
Idarubicin—ABCC1—Disease—NRG1—polycystic ovary syndrome	2.86e-05	0.00047	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—HMMR—polycystic ovary syndrome	2.61e-05	0.000428	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—HMMR—polycystic ovary syndrome	2.59e-05	0.000424	CbGpPWpGaD
Idarubicin—ABCC1—Disease—MTHFR—polycystic ovary syndrome	2.58e-05	0.000423	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—GNAS—polycystic ovary syndrome	2.56e-05	0.000421	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—HSD3B1—polycystic ovary syndrome	2.49e-05	0.000408	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—HSD3B1—polycystic ovary syndrome	2.47e-05	0.000405	CbGpPWpGaD
Idarubicin—ABCC1—Disease—IRS2—polycystic ovary syndrome	2.45e-05	0.000403	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—NCOR1—polycystic ovary syndrome	2.44e-05	0.000401	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	2.44e-05	0.0004	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—CYP1A1—polycystic ovary syndrome	2.32e-05	0.00038	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	2.31e-05	0.000379	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—LHB—polycystic ovary syndrome	2.27e-05	0.000372	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—LHB—polycystic ovary syndrome	2.25e-05	0.000369	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—HSD3B2—polycystic ovary syndrome	2.22e-05	0.000364	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—HSD3B2—polycystic ovary syndrome	2.2e-05	0.000361	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—MTHFR—polycystic ovary syndrome	2.16e-05	0.000354	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—AKR1C1—polycystic ovary syndrome	2.15e-05	0.000353	CbGpPWpGaD
Idarubicin—ABCC1—Disease—IRS1—polycystic ovary syndrome	2.14e-05	0.000351	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—AKR1C1—polycystic ovary syndrome	2.13e-05	0.000349	CbGpPWpGaD
Idarubicin—ABCC1—Disease—INS—polycystic ovary syndrome	2.05e-05	0.000337	CbGpPWpGaD
Idarubicin—ABCC1—Disease—AKT2—polycystic ovary syndrome	1.98e-05	0.000325	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—SULT2A1—polycystic ovary syndrome	1.98e-05	0.000324	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—SULT2A1—polycystic ovary syndrome	1.96e-05	0.000322	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—RRM2—polycystic ovary syndrome	1.91e-05	0.000314	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—RRM2—polycystic ovary syndrome	1.9e-05	0.000311	CbGpPWpGaD
Idarubicin—ABCC1—Disease—SERPINE1—polycystic ovary syndrome	1.88e-05	0.000309	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—YAP1—polycystic ovary syndrome	1.84e-05	0.000303	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—YAP1—polycystic ovary syndrome	1.83e-05	0.0003	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—NAMPT—polycystic ovary syndrome	1.77e-05	0.000291	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—NAMPT—polycystic ovary syndrome	1.76e-05	0.000288	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—PPARG—polycystic ovary syndrome	1.75e-05	0.000287	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—CYP11A1—polycystic ovary syndrome	1.75e-05	0.000287	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	1.75e-05	0.000287	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—CYP11A1—polycystic ovary syndrome	1.74e-05	0.000285	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—POMC—polycystic ovary syndrome	1.73e-05	0.000283	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	1.72e-05	0.000283	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—INS—polycystic ovary syndrome	1.72e-05	0.000282	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—AKR1C3—polycystic ovary syndrome	1.65e-05	0.000271	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—AKR1C3—polycystic ovary syndrome	1.64e-05	0.000269	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—CYP17A1—polycystic ovary syndrome	1.63e-05	0.000267	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—CYP17A1—polycystic ovary syndrome	1.61e-05	0.000265	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—TH—polycystic ovary syndrome	1.41e-05	0.000231	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—TH—polycystic ovary syndrome	1.4e-05	0.000229	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—SLC2A4—polycystic ovary syndrome	1.37e-05	0.000225	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—SLC2A4—polycystic ovary syndrome	1.36e-05	0.000223	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—CYP19A1—polycystic ovary syndrome	1.29e-05	0.000211	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—CYP19A1—polycystic ovary syndrome	1.28e-05	0.00021	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—GNAS—polycystic ovary syndrome	1.15e-05	0.000189	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—GNAS—polycystic ovary syndrome	1.14e-05	0.000187	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—NCOR1—polycystic ovary syndrome	1.1e-05	0.00018	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—NCOR1—polycystic ovary syndrome	1.09e-05	0.000178	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—CYP1A1—polycystic ovary syndrome	1.04e-05	0.00017	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—CYP1A1—polycystic ovary syndrome	1.03e-05	0.000169	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—MTHFR—polycystic ovary syndrome	9.68e-06	0.000159	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—MTHFR—polycystic ovary syndrome	9.59e-06	0.000158	CbGpPWpGaD
Idarubicin—ABCC1—Disease—IL6—polycystic ovary syndrome	8.96e-06	0.000147	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—PPARG—polycystic ovary syndrome	7.85e-06	0.000129	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—PPARG—polycystic ovary syndrome	7.78e-06	0.000128	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—POMC—polycystic ovary syndrome	7.74e-06	0.000127	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—INS—polycystic ovary syndrome	7.7e-06	0.000126	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—POMC—polycystic ovary syndrome	7.67e-06	0.000126	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—INS—polycystic ovary syndrome	7.63e-06	0.000125	CbGpPWpGaD
